Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA minor revision identifier on the page footer was updated from version v3.5.2 to v3.5.3. This reflects a behind-the-scenes release rather than a change to the study’s content.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision updated to v3.5.0; added Genetic and Rare Diseases Information Center resources and the Hepatocellular carcinoma term.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1, indicating a minor maintenance update that does not affect the study details.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.